Cargando…

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013

The Melanoma Independent Board (MIB) held its first conference from 21 to 22 October, 2013, in Rome, Italy. Like the MIB itself, the conference brought together specialists from all aspects of cancer care: doctors, patient associations, journalists, and representatives from local government, hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testori, A, Ascierto, P, Chiarion Sileni, V, De Lorenzo, F, Pelicci, PG, Rossi, CR
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2014
Materias:	Conference Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096026/ https://www.ncbi.nlm.nih.gov/pubmed/25075214 http://dx.doi.org/10.3332/ecancer.2014.440

Ejemplares similares

Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
por: Testori, Alessandro, et al.
Publicado: (2015)

Surgery and radiotherapy in the treatment of cutaneous melanoma
por: Testori, A., et al.
Publicado: (2009)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma
por: Russo, Irene, et al.
Publicado: (2018)

Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib
por: Valpione, Sara, et al.
Publicado: (2015)

Melanoma M (Zero): Diagnosis and Therapy
por: Rastrelli, Marco, et al.
Publicado: (2013)

Canadian Melanoma Conference Recommendations on High-Risk Melanoma Surveillance: A Report from the 14th Annual Canadian Melanoma Conference; Banff, Alberta; 20–22 February 2020
por: Lee, Christina W., et al.
Publicado: (2021)

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy
por: Chiarion-Sileni, V, et al.
Publicado: (2014)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
por: Valpione, Sara, et al.
Publicado: (2015)

UV exposure and melanoma prognostic factors : results from Clinical National Melanoma Registry (CNMR)
por: Montella, Maurizio, et al.
Publicado: (2014)

Report on the 2013 European Multidisciplinary Cancer Congress—ECC 17, Amsterdam, 27 September–1 October 2013: nursing highlights
por: Caruso, Rosario, et al.
Publicado: (2013)

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme
por: Altomonte, Maresa, et al.
Publicado: (2013)

Abstracts from the 11(th )Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC), October 21–22, 2007, La Jolla, California, USA
Publicado: (2007)

Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
por: Guida, Michele, et al.
Publicado: (2003)

A gene expression signature associated with survival in metastatic melanoma
por: Mandruzzato, Susanna, et al.
Publicado: (2006)

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme
por: Chiarion Sileni, Vanna, et al.
Publicado: (2014)

The immune cell landscape of metastatic uveal melanoma correlates with overall survival
por: Tosi, Anna, et al.
Publicado: (2021)

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
por: Queirolo, Paola, et al.
Publicado: (2014)

Abstracts of the Fourth Brainstorming Research Assembly for Young Neuroscientists (BraYn), Italy, 20–22 October 2021
por: Ferrara, Giovanni
Publicado: (2022)

Clinical Robotic Surgery Association Fifth Worldwide Congress, Washington DC, 3–5 October 2013: Robotic Colorectal Surgery
por: Bianchi, Paolo Pietro, et al.
Publicado: (2014)

Agenda for the 54th Meeting of the Research Board, on 22 October 1981
por: Goldschmidt-Clermont, Yves
Publicado: (1981)

Memorandum for the 54th Meeting of the Research Board, on 22 October 1981
por: CERN. Geneva. Research Board, et al.
Publicado: (1981)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013
por: Ascierto, Paolo A, et al.
Publicado: (2014)

Highlights from the HIV Research for Prevention Conference (R4P),: 17–21 October 2016, Chicago, IL, USA
por: Vasan, Sandhya, et al.
Publicado: (2017)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Introduction of CHEP2013 in Amsterdam
por: Groep, David
Publicado: (2012)

Decision of the 54th Meeting of the Research Board held on 22 October 1981
por: Schopper, Herwig Franz
Publicado: (1981)

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
por: Valpione, Sara, et al.
Publicado: (2015)

Young women and breast cancer: challenges and answers—report from the Sixth Annual International Symposium, Mexico, 20–21 October 2014
por: Cordera, David Barros Sierra, et al.
Publicado: (2014)

SOS 22 nov
por: Fichet, Jacques Herve
Publicado: (2005)

Sun exposure and melanoma prognostic factors
por: GANDINI, SARA, et al.
Publicado: (2016)

Agenda for the 10th Meeting of the Research Board on Thursday, October 21, 1976
por: Allaby, James V
Publicado: (1976)

Decisions of the 10th Meeting of the Research Board held on 21 October, 1976
por: Van Hove, Léon Charles Prudent
Publicado: (1976)

Network management, MIBs and MPLS
por: Morris, Stephen B
Publicado: (2003)

MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
por: Jansen, R. L., et al.
Publicado: (1998)

Report from the Scientific Poster Session at the 15th Annual Cardiometabolic Health Congress Live Online, USA, 21–24 October 2020
Publicado: (2020)

The CMS Barrel Calorimeter Processor demonstrator (BCPv1) board evaluation
por: Loukas, Nikitas
Publicado: (2021)

Surgical management of melanoma: an EORTC Melanoma Group survey
por: Testori, A, et al.
Publicado: (2013)

CERN Bulletin Issue No. 21-22/2013
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7hjahl4f995mvn32lieonc6d9k